(Q34564988)

3 August 2017

1 reference

title

Is there an upper age limit for bone marrow transplantation? (English)

1 reference

3 August 2017

1 reference

Popplewell LL

1

1 reference

3 August 2017

Forman SJ

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Bone Marrow Transplantation

3 August 2017

published in

1 reference

3 August 2017

volume

29

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

277-284

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703382

3 August 2017

exact match

0 references

cites work

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

The association between high-dose cytarabine neurotoxicity and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

Risk factors for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703382

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703382

1 reference

Dimensions Publication ID

3 August 2017

1052889233

0 references

Fatcat ID

release_sojqmxi3knac3c3yco6zzi2fla

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sojqmxi3knac3c3yco6zzi2fla

24 November 2022

mapped directly with Wikidata item

1 reference